The inflammatory status of the elderly: The intestinal contribution

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 690, Issue 1-2, 2010, Pages 50-56

  Schiffrin, Eduardo J ^a   Morley, John E ^b   Donnet Hughes, Anne ^a   Guigoz, Yves ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aging; Inflammation; Intestinal mucosa; Microbiota; Probiotics

Indexed keywords

ALPHA INTERFERON; ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 6; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

ADAPTIVE IMMUNITY; AGED; AGING; CELL ACTIVATION; CHRONIC DISEASE; CHRONIC INFLAMMATION; DENDRITIC CELL; HUMAN; IMMUNE DYSREGULATION; INFLAMMATION; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE MUCOSA; LAMINA PROPRIA; MACROPHAGE; OXYGENATION; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; INTESTINES; METAGENOME; PROBIOTICS;

EID: 77955271210     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2009.07.011     Document Type: Review

References (98)

1. Kumar V., Abbas A.K., Fausto N., Mitchell R. Robbins Basic Pathology 2007, Saunders, Philadelphia, PA, USA.
2. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454(7203):428-435.
3. Ceradini D.J., Gurtner G.C. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc. Med. 2005, 15(2):57-63.
4. Barton G.M. A calculated response: control of inflammation by the innate immune system. J. Clin. Invest. 2008, 118(2):413-420.
5. Abellan van Kan G., Rolland Y.M., Morley J.E., Vellas B. Frailty: toward a clinical definition. J. Am. Med. Dir. Assoc. 2008, 9(2):71-72.
6. Morley J.E., Baumgartner R.N. Cytokine-related aging process. J. Gerontol. A: Biol. 2004, 59(9):M924-M929.
7. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296(5566):301-305.
8. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007, 449(7164):819-826.
9. Medzhitov R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 2001, 1(2):135-145.
10. Kawai T., Akira S. Antiviral signaling through pattern recognition receptors. J. Biochem. 2007, 141(2):137-145.
11. Okabe Y., Kawane K., Akira S., et al. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J. Exp. Med. 2005, 202(10):1333-1339.
12. Strober W., Murray P.J., Kitani A., Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat. Rev. Immunol. 2006, 6(1):9-20.
13. Mariathasan S., Monack D.M. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat. Rev. Immunol. 2007, 7(1):31-40.
14. Martinon F., Petrilli V., Mayor A., et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440(7081):237-241.
15. Franchi L., Eigenbrod T., Munoz-Planillo R., Nunez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol. 2009, 10(3):241-247.
16. Stetson D.B., Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 2006, 24(1):93-103.
17. Muruve D.A., Petrilli V., Zaiss A.K., et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 2008, 452(7183):103-107.
18. Macpherson A.J., Smith K. Mesenteric lymph nodes at the center of immune anatomy. J. Exp. Med. 2006, 203(3):497-500.
19. Schiffrin E.J., Donnet-Hughes A. Education of the mucosal immune system: the role of breast milk during bacterial colonisation of the neonatal intestine. Nutrition and Immunity 2006, 39-51. E. Mengheri, M. Roselli, M.S. Britti, A. Finamore (Eds.).
20. Arvans D.L., Vavricka S.R., Ren H., et al. Luminal bacterial flora determines physiological expression of intestinal epithelial cytoprotective heat shock proteins 25 and 72. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288(4):G696-G704.
21. Kelly D., Campbell J.I., King T.P., et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat. Immunol. 2004, 5(1):104-112.
22. Neish A.S., Gewirtz A.T., Zeng H., et al. Prokaryotic regulation of epithelial responses by inhibition of Ikappa B-alpha ubiquitination. Science 2000, 289(5484):1560-1563.
23. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118(2):229-241.
24. Cario E., Podolsky D.K. Intestinal epithelial TOLLerance versus inTOLLerance of commensals. Mol. Immunol. 2005, 42(8):887-893.
25. Sun C.M., Hall J.A., Blank R.B., et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 2007, 204(8):1775-1785.
26. Jiang D., Liang J., Fan J., et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 2005, 11(11):1173-1179.
27. Jantsch J., Chakravortty D., Turza N., et al. Hypoxia and hypoxia-inducible factor-1{alpha} modulate lipopolysaccharide-induced dendritic cell activation and function. J. Immunol. 2008, 180(7):4697-4705.
28. Rajakariar R., Newson J., Jackson E.K., et al. Nonresolving inflammation in gp91phox-/- mice, a model of human chronic granulomatous disease, has lower adenosine and cyclic adenosine 5'-monophosphate. J. Immunol. 2009, 182(5):3262-3269.
29. Han J., Ulevitch R.J. Limiting inflammatory responses during activation of innate immunity. Nat. Immunol. 2005, 6(12):1198-1205.
30. Schwab J.M., Chiang N., Arita M., Serhan C.N. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007, 447(7146):869-874.
31. Karin M., Lawrence T., Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006, 124(4):823-835.
32. Gouin J.P., Hantsoo L., Kiecolt-Glaser J.K. Immune dysregulation and chronic stress among older adults: a review. Neuroimmunomodulation 2008, 15(4-6):251-259.
33. Candore G., Aquino A., Balistreri C.R., et al. Inflammation, longevity, and cardiovascular diseases: role of polymorphisms of TLR4. Ann. N. Y. Acad. Sci. 2006, 1067:282-287.
34. Chen W.H., Kozlovsky B.F., Effros R.B., et al. Vaccination in the elderly: an immunological perspective. Trends Immunol. 2009, 30(7):351-359.
35. Trzonkowski P., Mysliwska J., Pawelec G., Mysliwski A. From bench to bedside and back: the SENIEUR protocol and the efficacy of influenza vaccination in the elderly. Biogerontology 2009, 10(1):83-94.
36. Chung H.Y., Cesari M., Anton S., et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res. Rev. 2009, 8(1):18-30.
37. Yung R.L., Julius A. Epigenetics, aging, and autoimmunity. Autoimmunity 2008, 41(4):329-335.
38. Franceschi C., Capri M., Monti D., et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 2007, 128(1):92-105.
39. Glass C.K., Witztum J.L. Atherosclerosis: the road ahead. Cell 2001, 104(4):503-516.
40. Arkan M.C., Hevener A.L., Greten F.R., et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 2005, 11(2):191-198.
41. Swift M.E., Burns A.L., Gray K.L., DiPietro L.A. Age-related alterations in the inflammatory response to dermal injury. J. Invest. Dermatol. 2001, 117(5):1027-1035.
42. Wise C.M. Crystal-associated arthritis in the elderly. Clin. Geriatr. Med. 2005, 21(3):491-511.
43. Cabal A., onso-Cortina V., Gonzalez-Vazquez L.O., et al. [beta]-Amyloid precursor protein ([beta]-APP) in human gut with special reference to the enteric nervous system. Brain Res. Bull. 1995, 38(5):417-423.
44. Jana M., Palencia C.A., Pahan K. Fibrillar amyloid-{beta} peptides activate microglia via TLR2: implications for Alzheimer's disease. J. Immunol. 2008, 181(10):7254-7262.
45. Halle A., Hornung V., Petzold G.C., et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-[beta]. Nat. Immunol. 2008, 9(8):857-865.
46. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 1988, 318(20):1315-1321.
47. Lin L. RAGE on the toll road?. Cell Mol. Immunol. 2006, 3(5):351-358.
48. Febbraio M., Podrez E.A., Smith J.D., et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 2000, 105(8):1049-1056.
49. Hodgkinson C.P., Laxton R.C., Patel K., Ye S. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2008, 28(12):2275-2281.
50. Bhutto A., Morley J.E. The clinical significance of gastrointestinal changes with aging. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11(5):651-660.
51. John B.J., Abulafi A.M., Poullis A., Mendall M.A. Chronic subclinical bowel inflammation may explain increased risk of colorectal cancer in obese people 431. Gut 2007, 56(7):1034-1035.
52. Guigoz Y., Doré J., Schiffrin E.J. The inflammatory status of old age can be nurtured from the intestinal environment. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11(1):13-20.
53. Hopkins M.J., Sharp R., Macfarlane G.T. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 2001, 48(2):198-205.
54. Woodmansey E.J. Intestinal bacteria and ageing. J. Appl. Microbiol. 2007, 102(5):1178-1186.
55. Mariat D., Firmesse O., Levenez F., et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 2009, 9(1):123.
56. Coombes J.L., Powrie F. Dendritic cells in intestinal immune regulation. Nat. Rev. Immunol. 2008, 8(6):435-446.
57. Maloy K.J. The Interleukin-23/Interleukin-17 axis in intestinal inflammation. J. Intern. Med. 2008, 263(6):584-590.
58. Agrawal A., Agrawal S., Tay J., Gupta S. Biology of dendritic cells in aging. J. Clin. Immunol. 2008, 28(1):14-20.
59. Min H., Montecino-Rodriguez E., Dorshkind K. Effects of aging on the common lymphoid progenitor to pro-B cell transition. J. Immunol. 2006, 176(2):1007-1012.
60. Hannoun C., Megas F., Piercy J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res. 2004, 103(1-2):133-138.
61. Haynes L., Swain S.L. Why aging T cells fail: implications for vaccination. Immunity 2006, 24(6):663-666.
62. Aydar Y., Balogh P., Tew J.G., Szakal A.K. Follicular dendritic cells in aging, a " bottle-neck" in the humoral immune response. Ageing Res. Rev. 2004, 3(1):15-29.
63. Siegrist C.A., Aspinall R. B-cell responses to vaccination at the extremes of age. Nat. Rev. Immunol. 2009, 9(3):185-194.
64. Steinmann G.G. Changes in the human thymus during aging. Curr. Top. Pathol. 1986, 75:43-88.
65. Colonna-Romano G., Akbar A.N., Aquino A., et al. Impact of CMV and EBV seropositivity on CD8 T lymphocytes in an old population from West-Sicily. Exp. Gerontol. 2007, 42(10):995-1002.
66. + T cell clonotype which does not occur in young adults. Immun. Ageing 2008, 5(1):14.
67. Pawelec G., Koch S., Franceschi C., Wikby A. Human immunosenescence: does it have an infectious component?. Ann. N. Y. Acad. Sci. 2006, 1067:56-65.
68. Kiecolt-Glaser J.K., Preacher K.J., MacCallum R.C., et al. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc. Natl. Acad. Sci. U.S.A. 2003, 100(15):9090-9095.
69. Agrawal A., Tay J., Ton S., et al. Increased reactivity of dendritic cells from aged subjects to self-antigen, the human DNA. J. Immunol. 2009, 182(2):1138-1145.
70. Agrawal A., Agrawal S., Cao J.N., et al. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J. Immunol. 2007, 178(11):6912-6922.
71. Arroyo-Espliguero R., Avanzas P., Jeffery S., Kaski J.C. CD14 and toll-like receptor 4: a link between infection and acute coronary events?. Heart 2004, 90(9):983-988.
72. Dorshkind K., Montecino-Rodriguez E., Signer R.A.J. The ageing immune system: is it ever too old to become young again?. Nat. Rev. Immunol. 2009, 9(1):57-62.
73. Hamilton-Miller J.M.T. Probiotics and prebiotics in the elderly. Postgrad. Med. J. 2004, 80(946):447-451.
74. Bunout D., Hirsch S., de la Maza M.P., et al. Effects of prebiotics on the immune response to vaccination in the elderly. JPEN J. Parenter. Enteral. Nutr. 2002, 26(6):372-376.
75. Guigoz Y., Rochat F., Perruisseau-Carrier G., et al. Effects of oligosaccharide on the faecal flora and non-specific immune system in elderly people 345. Nutr. Res. 2002, 22:13-25.
76. Schiffrin E.J., Thomas D.R., Kumar V.B., et al. Systemic inflammatory markers in older persons: the effect of oral nutritional supplementation with prebiotics. J. Nutr. Health Aging 2007, 11(6):475-479.
77. Vulevic J., Drakoularakou A., Yaqoob P., et al. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am. J. Clin. Nutr. 2008, 88(5):1438-1446.
78. Gill H.S., Rutherfurd K.J., Cross M.L. Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J. Clin. Immunol. 2001, 21(4):264-271.
79. Takeda K., Okumura K. Effects of a fermented milk drink containing Lactobacillus casei strain shirota on the human NK-cell activity. J. Nutr. 2007, 137(3):791S-793.
80. Gill H.S., Rutherfurd K.J., Cross M.L., Gopal P.K. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am. J. Clin. Nutr. 2001, 74(6):833-839.
81. Turchet P., Laurenzano M., Auboiron S., Antoine J.M. Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study. J. Nutr. Health Aging 2003, 7(2):75-77.
82. Matsumoto M., Benno Y. Anti-inflammatory metabolite production in the gut from the consumption of probiotic yogurt containing Bifidobacterium animalis subsp. lactis LKM512. Biosci. Biotechnol. Biochem. 2006, 70(6):1287-1292.
83. Anderson A.D.G., McNaught C.E., Jain P.K., MacFie J. Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 2004, 53(2):241-245.
84. de Vrese M., Winkler P., Rautenberg P., et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin. Nutr. 2005, 24(4):481-491.
85. Calder P.C. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol. Nutr. Food Res. 2008, 52(8):885-897.
86. Simopoulos A.P. Omega-3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr. 2002, 21(6):495-505.
87. Serhan C.N., Chiang N. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br. J. Pharmacol. 2008, 153(Suppl. 1):S200-S215.
88. Meydani S.N., Wu D. Nutrition and age-associated inflammation: implications for disease prevention. J. Parenter. Enteral. Nutr. 2008, 32(6):626-629.
89. Molls R.R., Ahluwalia N., Mastro A.M., et al. Nutritional status predicts primary subclasses of T cells and the lymphocyte proliferation response in healthy older women. J. Nutr. 2005, 135(11):2644-2650.
90. Maggini S., Wintergerst E.S., Beveridge S., Hornig D.H. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br. J. Nutr. 2007, 98(Suppl. 1):S29-S35.
91. Mocchegiani E., Malavolta M. Zinc-gene interaction related to inflammatory/immune response in ageing. Genes Nutr. 2008, 3(2):61-75.
92. Hoffmann P.R., Berry M.J. The influence of selenium on immune responses. Mol. Nutr. Food Res. 2008, 52(11):1273-1280.
93. O'Hara A.M., Shanahan F. Gut microbiota: mining for therapeutic potential. Clin. Gastroenterol. Hepatol. 2007, 5(3):274-284.
94. Schiffrin E.J., Yousfi M.E., Faure M., et al. Milk casein-based diet containing TGF-{beta} controls the inflammatory reaction in the HLA-B27 transgenic rat model. J. Parenter. Enteral. Nutr. 2005, 29(Suppl. 4):S141-S150.
95. von Boehmer H. Oral tolerance: is it all retinoic acid?. J. Exp. Med. 2007, 204(8):1737-1739.
96. + T cells. Mucosal Immunol. 2008, 1(1):38-48.
97. Strober W., Vitamin A rewrites the ABCs of oral tolerance. Mucosal Immunol. 2008, 1(2):92-95.
98. Lesourd B. Nutritional factors and immunological ageing. Proc. Nutr. Soc. 2006, 65(3):319-325.